Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (531) Cernevit, Baxter Healthcare,
...infusion) is a lyophilized, sterile powder containing both water soluble and fat soluble vitamins (except Vitamin K) combined with mixed micelles (glycocholic acid and lecithin) in a single-dose amber glass vial ...
View Page

2.  Study Posting (4519) Trial #159798, Malignant Melanoma, Dallas, TX
...will evaluate the effect of RO5185426 on the pharmacokinetics of five CYP450 substrates (caffeine, warfarine + vitamin K, omeprazole, dextromethorphan, midazolam) administered as a drug cocktail to patients with metastatic melanoma. The study ...
View Page

3.  Study Posting (4519) Trial #159802, Malignant Melanoma, Nashville, TN
...will evaluate the effect of RO5185426 on the pharmacokinetics of five CYP450 substrates (caffeine, warfarine + vitamin K, omeprazole, dextromethorphan, midazolam) administered as a drug cocktail to patients with metastatic melanoma. The study ...
View Page

4.  Study Posting (4519) Trial #159796, Malignant Melanoma, Boston, MA
...will evaluate the effect of RO5185426 on the pharmacokinetics of five CYP450 substrates (caffeine, warfarine + vitamin K, omeprazole, dextromethorphan, midazolam) administered as a drug cocktail to patients with metastatic melanoma. The study ...
View Page

5.  Study Posting (4519) Trial #159800, Malignant Melanoma, Los Angeles, CA
...will evaluate the effect of RO5185426 on the pharmacokinetics of five CYP450 substrates (caffeine, warfarine + vitamin K, omeprazole, dextromethorphan, midazolam) administered as a drug cocktail to patients with metastatic melanoma. The study ...
View Page

6.  Study Posting (1570) Trial #156483, Atrial Fibrillation, Morristown, NJ
...called "atrial fibrillation". Patient Inclusion Criteria: • Non valvular atrial fibrillation (AF) • Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

7.  Study Posting (5479) Trial #162088, Atrial Fibrillation, Wauwatosa, WI
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

8.  Study Posting (5479) Trial #162087, Atrial Fibrillation, Madison, WI
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

9.  Study Posting (5479) Trial #162086, Atrial Fibrillation, Beloit, WI
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

10.  Study Posting (5479) Trial #162085, Atrial Fibrillation, Tacoma, WA
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

11.  Study Posting (5479) Trial #162084, Atrial Fibrillation, Seattle, WA
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

12.  Study Posting (5479) Trial #162083, Atrial Fibrillation, Everett, WA
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

13.  Study Posting (5479) Trial #162082, Atrial Fibrillation, Salem, VA
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

14.  Study Posting (5479) Trial #162081, Atrial Fibrillation, Burke, VA
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

15.  Study Posting (5479) Trial #162080, Atrial Fibrillation, Salt Lake City, UT
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

16.  Study Posting (5479) Trial #162079, Atrial Fibrillation, Salt Lake City, UT
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

17.  Study Posting (5479) Trial #162078, Atrial Fibrillation, Clinton, UT
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

18.  Study Posting (5479) Trial #162077, Atrial Fibrillation, Wichita Falls, TX
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

19.  Study Posting (5479) Trial #162076, Atrial Fibrillation, Victoria, TX
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page

20.  Study Posting (5479) Trial #162075, Atrial Fibrillation, Temple, TX
...until the trial ends. Inclusion Criteria: * Non valvular atrial fibrillation (AF) * Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack or ...
View Page